Elyxium Wealth, LLC
Source: SEC Form 13F · as of Mar 2026Elyxium Wealth, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $15.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$15.8M
| Company | Shares | Value |
|---|---|---|
| IDXXIDEXX LABORATORIES INC /DE | 12,971 | $7.3M |
| JNJJOHNSON & JOHNSON | 7,277 | $1.8M |
| LLYELI LILLY & Co | 1,652 | $1.5M |
| ABBVAbbVie Inc. | 3,995 | $869K |
| AMGNAMGEN INC | 2,015 | $709K |
| PMPhilip Morris International Inc | 3,986 | $659K |
| MRKMerck & Co., Inc. | 5,090 | $612K |
| PFEPFIZER INC | 16,419 | $461K |
| MCKMcKesson Corporation | 458 | $396K |
| GILDGILEAD SCIENCES, INC. | 2,461 | $343K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,246 | $337K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 657 | $293K |
| NVSNovartis AG | 1,820 | $278K |
| ABTABBOTT LABORATORIES | 2,498 | $256K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.